PATENT CLAIM ANALYSIS

Application Number: 15984855
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "283000"]

Abstract:
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Claim (Index 31):
The compound according to  claim 1  for treating cancer.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.44444
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15849905', '15938001', '15829541', '14735254', '11710582']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7845685014491176
- 35 USC 102 Novelty (BERT): 0.5116907574353137
- Combined Prediction Score: 0.7572807270477372
- Mean Citation Score: 305.186724
- Max Citation Score: 338.83557
- Similarity Product: 234.2285184532857

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test